4YC-33711-83953
4 vaccinations
0 coded responses
46 check-ins
0 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 117 / NY
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
T5E-61124-46307
Child or adolescent in my care · Male · 2022-07-15
PCR-23107-34646
Child or adolescent in my care · Male · 2022-07-15
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Health check-in — day 0, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Report sent to call center — day 0, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
-
2021-03-21
Health check-in — day 7, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-03-28
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-04
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-06
- 2021-04-08
- 2021-04-24
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-02
- 2021-10-01
-
2021-10-03
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2022-01-02
- 2022-04-03
- 2022-10-03
-
2022-11-10
Dose 4 — Pfizer-BioNTech
- 2022-11-12
- 2022-11-13
- 2022-11-14
- 2022-11-15
- 2022-11-16
- 2022-11-17
- 2022-11-24
- 2022-12-03
- 2022-12-08
- 2022-12-15
- 2022-12-22
- 2023-02-09
- 2023-05-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-10-03 | Pfizer-BioNTech | No |
| 4 | 2022-11-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-12 | priority 2/3 | |
| 2021-03-13 | priority 2/3 | |
| 2021-03-21 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.